Become a Member and get exclusive discounted Prices and Deals.

GPS Cancer

NantHealthSKU: NH-GPS-I4-SD

As an oncologist, difficult treatment decisions are a daily reality. By offering a precise and comprehensive molecular tumor profile, GPS Cancer reveal unprecedented insights into the molecular signature of each patient’s cancer. These insights can inform personalized treatment strategies.
Full Description

Each unique profile includes:

  • Whole genome/exome sequencing of 20,000 genes and 3 billion base pairs
  • Whole transcriptome sequencing of more than 200,000 RNA transcripts
  • Comparison of a patient’s tumor genome to their normal genome and provides pharmacogenomic analysis for potential drug toxicity and/or interactions

GPS Cancer offers molecular insights into therapies that may benefit patients—including FDA-approved therapies and active clinical trials—as well as therapies to which the cancer may be resistant. All GPS Cancer sequencing is performed in CAP-accredited, CLIA-certified labs.

Customer Review